- ATRIP Intellectual Property series
Edited by Jan Rosén
Chapter 6: Commercialization of genetic resources: leveraging ex situ genetic resources to shape downstream IP protection
Plant and microbial genetic resources exist in natural habitats and culture collections worldwide. Their scientific and economic value is rapidly gaining in importance, even though the laws governing them do not support ease of use. Genetic resources are subject to the overlapping jurisdiction of the Convention on Biological Diversity (CBD) and the Agreement on Trade Related Aspects of Intellectual Property (TRIPS). Neither of these regimes operates in a particularly access-friendly manner with respect to biological resources with imminent commercial potential. The CBD entitles countries to share benefits arising out of the use of resources originating in their territories. The scope, nature and duration of CBD obligations, and consequently of potential claims, are, however, often vague. Patent laws enacted under TRIPS, in a context of a strong growth market, fragmented patents and expensive product development, tend to function sub-optimally and allow formation of blocking patents and patent thickets. In combination, these regimes encourage a race to extract value by the beneficiaries of the entitlements created, which tends to diminish the ability to exploit high-value biological resources.
You are not authenticated to view the full text of this chapter or article.
Elgaronline requires a subscription or purchase to access the full text of books or journals. Please login through your library system or with your personal username and password on the homepage.
Non-subscribers can freely search the site, view abstracts/ extracts and download selected front matter and introductory chapters for personal use.
Your library may not have purchased all subject areas. If you are authenticated and think you should have access to this title, please contact your librarian.